Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α
產(chǎn)品名稱: Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α
產(chǎn)品型號: C22-204-20
產(chǎn)品展商: PERFEMIKER
產(chǎn)品文檔: 無相關(guān)文檔
簡單介紹
Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α 現(xiàn)貨促銷，>97% by SDS-PAGE and HPLC analyses.
Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α
的詳細介紹
產(chǎn)品名稱：Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α
單 位：支
Recombinant Human MIP-3 alpha (CCL20)|重組人巨噬細胞炎性蛋白-3α ，國產(chǎn)細胞因子,cytokine
產(chǎn)品詳細介紹：
C22-204-20 5μg/￥500 20μg/￥1000 1mg/詢價
Purity:
>97% by SDS-PAGE and HPLC analyses.
Biological Activity:
Fully biologically active when compared to standard. Determined by its ability to chemoattract
human T lymphocytes using a concentration range of 10.0 -50.0 ng/ml.
Storage:
This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage,
preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For
maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to
-70°C. Avoid repeated freeze/thaw cycles.
